Biogen Inc.
145.06
2.00 (1.40%)
At close: Jan 15, 2025, 9:53 AM

Biogen Inc. Revenue Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Sep 30, 2020Jun 30, 2020Mar 31, 2020Sep 30, 2019Jun 30, 2019Mar 31, 2019Sep 30, 2018Jun 30, 2018Mar 31, 2018
Fumarate Revenue 390.90M 418.00M 381.80M 405.00M 400.40M 382.70M 447.90M 476.80M 534.70M 537.90M 611.40M 619.50M 578.50M 552.90M 967.50M 1.19B 466.00M 530.00M 554.40M 500.90M 590.10M 625.50M 550.30M
Fumarate Revenue Growth -6.48% +9.48% -5.73% +1.15% +4.63% -14.56% -6.06% -10.83% -0.59% -12.02% -1.31% +7.09% +4.63% -42.85% -18.72% +155.43% -12.08% -4.40% +10.68% -15.12% -5.66% +13.67% n/a
Interferon Revenue 237.50M 250.90M 243.60M 277.70M 302.40M 245.60M 309.60M 336.00M 350.20M 309.60M 377.70M 387.50M 400.40M 400.50M 474.10M 481.40M 2.12B 2.16B 2.20B 1.98B 467.70M 422.70M 363.90M
Interferon Revenue Growth -5.34% +3.00% -12.28% -8.17% +23.13% -20.67% -7.86% -4.05% +13.11% -18.03% -2.53% -3.22% -0.02% -15.52% -1.52% -77.27% -1.98% -1.99% +11.14% +323.99% +10.65% +16.16% n/a
MS Product Revenues Revenue 1.05B 1.15B 1.08B 1.16B 1.21B 1.13B 1.27B 1.34B 1.43B 1.39B 1.53B 1.56B 1.53B 1.48B 1.98B 2.13B 565.00M 547.10M 488.20M 518.50M 470.20M 467.20M 462.10M
MS Product Revenues Revenue Growth -8.34% +6.87% -7.17% -4.16% +7.47% -11.32% -5.33% -6.05% +2.30% -8.75% -1.79% +1.75% +3.09% -25.27% -6.67% +276.41% +3.27% +12.06% -5.84% +10.27% +0.64% +1.10% n/a
SPINRAZA Revenue 381.40M 429.10M 341.30M 448.20M 437.10M 443.30M 458.80M 431.10M 431.10M 472.50M 440.80M 444.10M 499.70M 520.50M 494.40M 494.60M 522.40M 483.60M 475.30M 460.40M n/a n/a n/a
SPINRAZA Revenue Growth -11.12% +25.73% -23.85% +2.54% -1.40% -3.38% +6.43% 0.00% -8.76% +7.19% -0.74% -11.13% -4.00% +5.28% -0.04% -5.32% +8.02% +1.75% +3.24% n/a n/a n/a n/a
TYSABRI product Revenue 406.10M 462.20M 431.30M 456.30M 483.10M 472.80M 488.40M 505.50M 516.20M 520.80M 512.80M 522.80M 524.20M 503.30M 516.50M 432.00M n/a n/a n/a n/a n/a n/a n/a
TYSABRI product Revenue Growth -12.14% +7.16% -5.48% -5.55% +2.18% -3.19% -3.38% -2.07% -0.88% +1.56% -1.91% -0.27% +4.15% -2.56% +19.56% n/a n/a n/a n/a n/a n/a n/a n/a

Revenue by Geography

Quarter Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017Dec 31, 2016Dec 31, 2015Dec 31, 2014Dec 31, 2013Dec 31, 2012Dec 31, 2011Dec 31, 2010
Asia Revenue 672.10M 688.00M 596.70M 320.30M 281.20M 3.29B 3.17B 2.91B 2.43B 93.20M 2.18B 1.95B 69.00M
Asia Revenue Growth -2.31% +15.30% +86.29% +13.90% -91.46% +3.93% +8.98% +19.85% +2503.65% -95.72% +11.36% +2733.04% n/a
Europe Revenue 2.40B 2.63B 3.66B 3.79B 3.37B n/a n/a n/a n/a 1.17B n/a n/a 1.09B
Europe Revenue Growth -8.56% -28.18% -3.64% +12.59% n/a n/a n/a n/a n/a n/a n/a n/a n/a
Germany Revenue 926.20M 1.16B 5.90B 6.71B 1.90B n/a n/a n/a n/a 417.70M n/a n/a 1.74B
Germany Revenue Growth -20.32% -80.30% -12.12% +252.73% n/a n/a n/a n/a n/a n/a n/a n/a n/a
United States Revenue 3.47B 3.81B n/a n/a n/a n/a n/a n/a n/a 3.58B n/a n/a 362.40M
United States Revenue Growth -8.84% n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a

Operating Expense Breakdown

Quarter Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021Sep 30, 2021Jun 30, 2021Mar 31, 2021Dec 31, 2020Sep 30, 2020Jun 30, 2020Mar 31, 2020Dec 31, 2019Sep 30, 2019Jun 30, 2019Mar 31, 2019Dec 31, 2018Sep 30, 2018Jun 30, 2018Mar 31, 2018Dec 31, 2017Sep 30, 2017Jun 30, 2017Mar 31, 2017Dec 31, 2016Sep 30, 2016Jun 30, 2016Mar 31, 2016Dec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
Selling, General, and Administrative Revenue 588.40M 553.80M 581.50M 608.50M 788.20M 548.00M 605.00M 632.80M 563.30M 572.60M 634.90M 787.90M 654.10M 637.30M 595.00M 806.30M 573.10M 555.10M 570.10M 664.90M 554.50M 587.60M 567.70M 591.10M 497.70M 516.20M 501.30M 572.40M 433.80M 430.20M 499.10M 495.50M 462.70M 492.40M 497.30M 583.00M 477.83M 491.89M 560.36M
Selling, General, and Administrative Revenue Growth +6.25% -4.76% -4.44% -22.80% +43.83% -9.42% -4.39% +12.34% -1.62% -9.81% -19.42% +20.46% +2.64% +7.11% -26.21% +40.69% +3.24% -2.63% -14.26% +19.91% -5.63% +3.51% -3.96% +18.77% -3.58% +2.97% -12.42% +31.95% +0.84% -13.80% +0.73% +7.09% -6.03% -0.99% -14.70% +22.01% -2.86% -12.22% n/a
Research and Development Revenue 542.70M 442.00M 383.60M 570.90M 736.30M 584.20M 570.60M 601.60M 549.20M 528.60M 551.70M 699.50M 702.40M 585.10M 514.20M 1.73B 1.14B 647.60M 476.30M 691.70M 540.40M 484.80M 563.70M 611.60M 507.90M 981.00M 496.70M 587.60M 446.40M 796.20M 423.40M 533.90M 529.00M 473.10M 437.30M 541.70M 519.86M 490.73M 460.55M
Research and Development Revenue Growth +22.78% +15.22% -32.81% -22.46% +26.04% +2.38% -5.15% +9.54% +3.90% -4.19% -21.13% -0.41% +20.05% +13.79% -70.21% +51.28% +76.17% +35.96% -31.14% +28.00% +11.47% -14.00% -7.83% +20.42% -48.23% +97.50% -15.47% +31.63% -43.93% +88.05% -20.70% +0.93% +11.82% +8.19% -19.27% +4.20% +5.94% +6.55% n/a

Create Price Alert on BIIB

Your price alert will notify you when the stock price is above 145.06.

Add to Watchlist